Rab3a promotes brain tumor initiation and progression

Jun-Kyum Kim1, Seung-Yup Lee, Chang-Won Park

  • 1Department of Biotechnology, School of Life Sciences and Biotechnology, Korea University, Seoul, Republic of Korea.

Insights

Rab3a, a protein involved in vesicle transport, acts as a novel oncogene in brain tumors. Its elevated expression promotes glioma cell proliferation, drug resistance, and tumor formation, highlighting its role in cancer development.

Area of Science:

  • Neuroscience
  • Oncology
  • Molecular Biology

Background:

  • Rab proteins are key regulators of intracellular vesicle trafficking.
  • Rab3a is specifically linked to synaptic vesicle trafficking in the brain.
  • The role of elevated Rab3a in tumor development is currently unclear.

Purpose of the Study:

  • To investigate the potential tumorigenic role of Rab3a in brain tumors.
  • To confirm Rab3a expression levels in glioma and glioblastoma specimens.
  • To elucidate the mechanisms by which Rab3a influences glioma progression.

Main Methods:

  • Analysis of Rab3a expression in human glioma cell lines and patient samples.
  • Overexpression of Rab3a in glioma cells and primary astrocytes.
  • Assays for cell proliferation, drug/irradiation resistance, foci formation, and tumorsphere formation.
  • Assessment of stem cell marker expression.

Main Results:

  • Elevated Rab3a expression was confirmed in human glioma and glioblastoma.
  • Ectopic Rab3a expression enhanced cell proliferation, cyclin D1 levels, and resistance to therapy.
  • Rab3a overexpression promoted foci and tumor formation in vivo.
  • Rab3a augmented tumorsphere formation and stem cell marker expression.

Conclusions:

  • Rab3a functions as a novel oncogene in glioma.
  • Rab3a plays a significant role in glioma initiation and progression.
  • Targeting Rab3a may offer a therapeutic strategy for brain tumors.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
3.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
5.7K